ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers
Washington University School of Medicine
Washington University School of Medicine
Janssen Research & Development, LLC
Astellas Pharma Inc
Genmab
Amgen
Akeso
M.D. Anderson Cancer Center
iOnctura
OncoC4, Inc.
Shanghai Chest Hospital